Global Circulating Tumor Cell Kit Market Research Report 2024

Publication ID:

PB504243492

Publication Date:

April 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Circulating tumor cells are malignant tumor cells that originate from primary tumors and enter the systemic circulation. Detection of these cells in blood or other body fluids can help doctors diagnose tumors, assess disease progression, and predict treatment effects.
Circulating Tumor Cell Kit is a kit for the detection and analysis of circulating tumor cells (CTCs) in body fluids. Circulating Tumor Cell Kits typically include specific reagents and equipment for capturing, detecting, and analyzing circulating tumor cells. These kits can separate circulating tumor cells from body fluid samples through different technologies, such as immunomagnetic bead sorting, cell surface labeling, etc., and conduct further molecular biology or cytology analysis.
The global Circulating Tumor Cell Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Circulating Tumor Cell Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circulating Tumor Cell Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Circulating Tumor Cell Kit include Menarini Silicon Biosystems, Qiagen, STEMCELL Technologies, ScreenCell, Fluxion Biosciences, Biocept, pluriSelect, Roche, Hangzhou Watson Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell Kit.
The Circulating Tumor Cell Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Menarini Silicon Biosystems
Qiagen
STEMCELL Technologies
ScreenCell
Fluxion Biosciences
Biocept
pluriSelect
Roche
Hangzhou Watson Biotech
by Type
IVD
RUO
by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Circulating Tumor Cell Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Circulating Tumor Cell Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Circulating Tumor Cell Kit Market Overview
1.1 Product Definition
1.2 Circulating Tumor Cell Kit by Type
1.2.1 Global Circulating Tumor Cell Kit Market Value Comparison by Type (2024-2030)
1.2.2 IVD
1.2.3 RUO
1.3 Circulating Tumor Cell Kit by Application
1.3.1 Global Circulating Tumor Cell Kit Market Value by Application (2024-2030)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Global Circulating Tumor Cell Kit Market Size Estimates and Forecasts
1.4.1 Global Circulating Tumor Cell Kit Revenue 2019-2030
1.4.2 Global Circulating Tumor Cell Kit Sales 2019-2030
1.4.3 Global Circulating Tumor Cell Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Circulating Tumor Cell Kit Market Competition by Manufacturers
2.1 Global Circulating Tumor Cell Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Circulating Tumor Cell Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Circulating Tumor Cell Kit Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Circulating Tumor Cell Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Circulating Tumor Cell Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Circulating Tumor Cell Kit, Product Type & Application
2.7 Global Key Manufacturers of Circulating Tumor Cell Kit, Date of Enter into This Industry
2.8 Global Circulating Tumor Cell Kit Market Competitive Situation and Trends
2.8.1 Global Circulating Tumor Cell Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Circulating Tumor Cell Kit Players Market Share by Revenue
2.8.3 Global Circulating Tumor Cell Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Circulating Tumor Cell Kit Market Scenario by Region
3.1 Global Circulating Tumor Cell Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Circulating Tumor Cell Kit Sales by Region: 2019-2030
3.2.1 Global Circulating Tumor Cell Kit Sales by Region: 2019-2024
3.2.2 Global Circulating Tumor Cell Kit Sales by Region: 2025-2030
3.3 Global Circulating Tumor Cell Kit Revenue by Region: 2019-2030
3.3.1 Global Circulating Tumor Cell Kit Revenue by Region: 2019-2024
3.3.2 Global Circulating Tumor Cell Kit Revenue by Region: 2025-2030
3.4 North America Circulating Tumor Cell Kit Market Facts & Figures by Country
3.4.1 North America Circulating Tumor Cell Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Circulating Tumor Cell Kit Sales by Country (2019-2030)
3.4.3 North America Circulating Tumor Cell Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Circulating Tumor Cell Kit Market Facts & Figures by Country
3.5.1 Europe Circulating Tumor Cell Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Circulating Tumor Cell Kit Sales by Country (2019-2030)
3.5.3 Europe Circulating Tumor Cell Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Circulating Tumor Cell Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Circulating Tumor Cell Kit Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Circulating Tumor Cell Kit Sales by Region (2019-2030)
3.6.3 Asia Pacific Circulating Tumor Cell Kit Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Circulating Tumor Cell Kit Market Facts & Figures by Country
3.7.1 Latin America Circulating Tumor Cell Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Circulating Tumor Cell Kit Sales by Country (2019-2030)
3.7.3 Latin America Circulating Tumor Cell Kit Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Circulating Tumor Cell Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Circulating Tumor Cell Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Circulating Tumor Cell Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Circulating Tumor Cell Kit Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circulating Tumor Cell Kit Sales by Type (2019-2030)
4.1.1 Global Circulating Tumor Cell Kit Sales by Type (2019-2024)
4.1.2 Global Circulating Tumor Cell Kit Sales by Type (2025-2030)
4.1.3 Global Circulating Tumor Cell Kit Sales Market Share by Type (2019-2030)
4.2 Global Circulating Tumor Cell Kit Revenue by Type (2019-2030)
4.2.1 Global Circulating Tumor Cell Kit Revenue by Type (2019-2024)
4.2.2 Global Circulating Tumor Cell Kit Revenue by Type (2025-2030)
4.2.3 Global Circulating Tumor Cell Kit Revenue Market Share by Type (2019-2030)
4.3 Global Circulating Tumor Cell Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Circulating Tumor Cell Kit Sales by Application (2019-2030)
5.1.1 Global Circulating Tumor Cell Kit Sales by Application (2019-2024)
5.1.2 Global Circulating Tumor Cell Kit Sales by Application (2025-2030)
5.1.3 Global Circulating Tumor Cell Kit Sales Market Share by Application (2019-2030)
5.2 Global Circulating Tumor Cell Kit Revenue by Application (2019-2030)
5.2.1 Global Circulating Tumor Cell Kit Revenue by Application (2019-2024)
5.2.2 Global Circulating Tumor Cell Kit Revenue by Application (2025-2030)
5.2.3 Global Circulating Tumor Cell Kit Revenue Market Share by Application (2019-2030)
5.3 Global Circulating Tumor Cell Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Menarini Silicon Biosystems
6.1.1 Menarini Silicon Biosystems Company Information
6.1.2 Menarini Silicon Biosystems Description and Business Overview
6.1.3 Menarini Silicon Biosystems Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Menarini Silicon Biosystems Circulating Tumor Cell Kit Product Portfolio
6.1.5 Menarini Silicon Biosystems Recent Developments/Updates
6.2 Qiagen
6.2.1 Qiagen Company Information
6.2.2 Qiagen Description and Business Overview
6.2.3 Qiagen Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Qiagen Circulating Tumor Cell Kit Product Portfolio
6.2.5 Qiagen Recent Developments/Updates
6.3 STEMCELL Technologies
6.3.1 STEMCELL Technologies Company Information
6.3.2 STEMCELL Technologies Description and Business Overview
6.3.3 STEMCELL Technologies Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 STEMCELL Technologies Circulating Tumor Cell Kit Product Portfolio
6.3.5 STEMCELL Technologies Recent Developments/Updates
6.4 ScreenCell
6.4.1 ScreenCell Company Information
6.4.2 ScreenCell Description and Business Overview
6.4.3 ScreenCell Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ScreenCell Circulating Tumor Cell Kit Product Portfolio
6.4.5 ScreenCell Recent Developments/Updates
6.5 Fluxion Biosciences
6.5.1 Fluxion Biosciences Company Information
6.5.2 Fluxion Biosciences Description and Business Overview
6.5.3 Fluxion Biosciences Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fluxion Biosciences Circulating Tumor Cell Kit Product Portfolio
6.5.5 Fluxion Biosciences Recent Developments/Updates
6.6 Biocept
6.6.1 Biocept Company Information
6.6.2 Biocept Description and Business Overview
6.6.3 Biocept Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocept Circulating Tumor Cell Kit Product Portfolio
6.6.5 Biocept Recent Developments/Updates
6.7 pluriSelect
6.7.1 pluriSelect Company Information
6.7.2 pluriSelect Description and Business Overview
6.7.3 pluriSelect Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.7.4 pluriSelect Circulating Tumor Cell Kit Product Portfolio
6.7.5 pluriSelect Recent Developments/Updates
6.8 Roche
6.8.1 Roche Company Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Circulating Tumor Cell Kit Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Hangzhou Watson Biotech
6.9.1 Hangzhou Watson Biotech Company Information
6.9.2 Hangzhou Watson Biotech Description and Business Overview
6.9.3 Hangzhou Watson Biotech Circulating Tumor Cell Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hangzhou Watson Biotech Circulating Tumor Cell Kit Product Portfolio
6.9.5 Hangzhou Watson Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circulating Tumor Cell Kit Industry Chain Analysis
7.2 Circulating Tumor Cell Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circulating Tumor Cell Kit Production Mode & Process
7.4 Circulating Tumor Cell Kit Sales and Marketing
7.4.1 Circulating Tumor Cell Kit Sales Channels
7.4.2 Circulating Tumor Cell Kit Distributors
7.5 Circulating Tumor Cell Kit Customers
8 Circulating Tumor Cell Kit Market Dynamics
8.1 Circulating Tumor Cell Kit Industry Trends
8.2 Circulating Tumor Cell Kit Market Drivers
8.3 Circulating Tumor Cell Kit Market Challenges
8.4 Circulating Tumor Cell Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Menarini Silicon Biosystems
Qiagen
STEMCELL Technologies
ScreenCell
Fluxion Biosciences
Biocept
pluriSelect
Roche
Hangzhou Watson Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂